Treatment with cinacalcet increases plasma sclerostin concentration in hemodialysis patients with secondary hyperparathyroidism

被引：0
|
作者：
Piotr Kuczera
Marcin Adamczak
Andrzej Więcek
机构：
[1] Transplantation and Internal Medicine,Department of Nephrology
[2] Medical University of Silesia,undefined
来源：
BMC Nephrology | / 17卷
关键词：
Secondary hyperparathyroidism; Hemodialysis; Cinacalcet; Sclerostin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [21] REDUCED OXIDATIVE STRESS IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM TREATED WITH CINACALCET
    Kuczera, Piotr
    Adamczak, Marcin
    Machnik, Grzegorz
    Okopien, Boguslaw
    Wiecek, Andrzej
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32
  • [22] PTH-dependence of the effectiveness of cinacalcet in hemodialysis patients with secondary hyperparathyroidism
    Tadao Akizawa
    Noriaki Kurita
    Masahide Mizobuchi
    Masafumi Fukagawa
    Yoshihiro Onishi
    Takuhiro Yamaguchi
    Alan R. Ellis
    Shingo Fukuma
    M. Alan Brookhart
    Takeshi Hasegawa
    Kiyoshi Kurokawa
    Shunichi Fukuhara
    Scientific Reports, 6
  • [23] Dose determination of cinacalcet hydrochloride in Japanese hemodialysis patients with secondary hyperparathyroidism
    Akiba, Takashi
    Akizawa, Tadao
    Tsukamoto, Yusuke
    Uchida, Eiji
    Iwasaki, Manabu
    Koshikawa, Shozo
    THERAPEUTIC APHERESIS AND DIALYSIS, 2008, 12 (02) : 117 - 125
  • [24] Interrelationships Between Sclerostin, Secondary Hyperparathyroidism, and Bone Metabolism in Patients on Hemodialysis
    Nakagawa, Yosuke
    Komaba, Hirotaka
    Hamano, Naoto
    Tanaka, Hisae
    Wada, Takehiko
    Ishida, Hiroaki
    Nakamura, Michio
    Takahashi, Hiroo
    Takahashi, Yuichiro
    Hyodo, Toru
    Hida, Miho
    Suga, Takao
    Kakuta, Takatoshi
    Fukagawa, Masafumi
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2022, 107 (01): : E95 - E105
  • [25] Cinacalcet for secondary hyperparathyroidism in hemodialysis recipients - The authors reply
    Block, GA
    Goodman, WG
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (02): : 189 - 189
  • [26] Effect of cinacalcet on bone mineral density of the radius in hemodialysis patients with secondary hyperparathyroidism
    Ishimura, E.
    Okuno, S.
    Tsuboniwa, N.
    Ichii, M.
    Yamakawa, K.
    Yamakawa, T.
    Shoji, S.
    Nishizawa, Y.
    Inaba, M.
    CLINICAL NEPHROLOGY, 2011, 76 (04) : 259 - 265
  • [27] EFFICACY AND SAFETY OF ETELCALCETIDE IN HEMODIALYSIS PATIENTS WITH SECONDARY HYPERPARATHYROIDISM INADEQUATELY CONTROLLED WITH CINACALCET
    Takahashi, Hiroo
    Komaba, Hirotaka
    Takahashi, Ryo
    Takahashi, Yuichiro
    Fukagawa, Masafumi
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2018, 33
  • [28] Association of Nodular Hyperplasia With Resistance to Cinacalcet Therapy for Secondary Hyperparathyroidism in Hemodialysis Patients
    Hirai, Takayuki
    Nakashima, Ayumu
    Takasugi, Norihisa
    Yorioka, Noriaki
    THERAPEUTIC APHERESIS AND DIALYSIS, 2010, 14 (06) : 577 - 582
  • [29] IS THE CHANGE FROM CINACALCET TO ETELCALCETIDE SAFE AND EFFECTIVE IN PATIENTS ON HEMODIALYSIS WITH SECONDARY HYPERPARATHYROIDISM?
    Hadad Arrascue, Fernando
    Araque, Alicia
    Amair, Ruth
    Rosique, Florentina
    Perez Perez, Antonio
    Andreu Munoz, Alberto
    Cabezuelo-Romero, Juan
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1740 - 1740
  • [30] Analysis of the efficacy and factors influencing the response of secondary hyperparathyroidism patients on hemodialysis to cinacalcet
    Segura Torres, P.
    Borrego Utiel, F. J.
    Sanchez Perales, M. C.
    Garcia Cortes, M. J.
    Biechy Baldan, M. M.
    Perez Banasco, V.
    NEFROLOGIA, 2010, 30 (04): : 443 - 451
12345